Alnylam Pharmaceuticals shares owned by Legal & General Group
Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Legal & General Group
from 13F filings
Historical chart of Legal & General Group investment in Alnylam Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals held by Legal & General Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals by Legal & General Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $178M | 931k | 191.41 |
| 2023-09-30 | $141M | 795k | 177.10 |
| 2023-06-30 | $152M | 798k | 189.94 |
| 2023-03-31 | $146M | 731k | 200.32 |
| 2022-12-31 | $174M | 732k | 237.65 |
| 2022-09-30 | $151M | 755k | 200.16 |
| 2022-06-30 | $114M | 779k | 145.85 |
| 2022-03-31 | $124M | 757k | 163.29 |
| 2021-12-31 | $115M | 680k | 169.58 |
| 2021-09-30 | $126M | 667k | 188.81 |
| 2021-06-30 | $116M | 683k | 169.52 |
| 2021-03-31 | $91M | 646k | 141.18 |
| 2020-12-31 | $84M | 645k | 129.94 |
| 2020-09-30 | $92M | 631k | 145.61 |
| 2020-06-30 | $94M | 633k | 148.18 |
| 2020-03-31 | $70M | 604k | 115.60 |
| 2019-12-31 | $66M | 574k | 115.33 |
| 2019-09-30 | $43M | 533k | 80.42 |
| 2019-06-30 | $36M | 501k | 72.56 |
| 2019-03-31 | $44M | 475k | 93.45 |
| 2018-12-31 | $27M | 367k | 72.91 |
| 2018-09-30 | $30M | 340k | 87.52 |
| 2018-06-30 | $34M | 341k | 98.49 |
| 2018-03-31 | $42M | 349k | 119.10 |
| 2017-12-31 | $14M | 107k | 127.08 |
| 2017-09-30 | $3.8M | 32k | 117.65 |
| 2017-06-30 | $2.2M | 28k | 79.94 |
| 2017-03-31 | $1.3M | 25k | 51.60 |
| 2016-12-31 | $9.3M | 247k | 37.44 |
| 2016-09-30 | $20M | 293k | 67.78 |
| 2016-06-30 | $17M | 297k | 55.49 |
| 2016-03-31 | $18M | 292k | 62.77 |
| 2015-12-31 | $27M | 289k | 94.14 |
| 2015-09-30 | $22M | 279k | 80.36 |
| 2015-06-30 | $3.1M | 26k | 119.86 |
| 2015-03-31 | $242k | 2.3k | 104.45 |